Of note, HIF-1 alpha is reportedly associated with cancer progression and with up-regulation of several genes able to promote angiogenesis [37, 38], including VEGF/VEGFR, which is among the pathways currently selected for targeted therapy. This evidence concerns the gene KDR and cancer.